Cargando…

A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants

There remains a clear need for effective tumor cell purging in autologous stem cell transplantation (ASCT) where residual malignant cells within the autograft contribute to disease relapse. Here we propose the use of a novel Fas agonist with potent pro-apoptotic activity, termed MegaFasL, as an effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nahimana, A, Aubry, D, Lagopoulos, L, Greaney, P, Attinger, A, Demotz, S, Dawson, K M, Schapira, M, Tschopp, J, Dupuis, M, Duchosal, M A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255509/ https://www.ncbi.nlm.nih.gov/pubmed/22829095 http://dx.doi.org/10.1038/bcj.2011.47

Ejemplares similares

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
por: Breton, Caroline S, et al.
Publicado: (2014)

Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia
por: Matsumoto, Saki, et al.
Publicado: (2023)

T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis
por: Hao, Zhenyue, et al.
Publicado: (2004)

Apoptosis of Fas(high) CD4(+) Synovial T Cells by Borrelia-reactive Fas-ligand(high) γδ T Cells in Lyme Arthritis
por: Vincent, Michael S., et al.
Publicado: (1996)

T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy
por: Takahashi, Takuto, et al.
Publicado: (2022)

Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability
por: Pellegrin, Maxime, et al.
Publicado: (2018)

Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
por: El Fakih, Riad, et al.
Publicado: (2017)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future
por: Saad, A, et al.
Publicado: (2017)

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
por: Rådestad, Emelie, et al.
Publicado: (2019)

Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival
por: McIver, Zachariah A., et al.
Publicado: (2013)

Fist/Hipk3: A FAS/Fadd-Interacting Serine/Threonine Kinase That Induces Fadd Phosphorylation and Inhibits FAS-Mediated Jun Nh(2)-Terminal Kinase Activation
por: Rochat-Steiner, Véronique, et al.
Publicado: (2000)

A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency
por: Chodorge, M, et al.
Publicado: (2012)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
por: Hobbs, Gabriela Soriano, et al.
Publicado: (2015)

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
por: Cagnetta, Antonia, et al.
Publicado: (2018)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Long Term Renal Survival in Patients undergoing T-Cell Depleted vs Conventional Hematopoietic Stem Cell Transplants
por: Glezerman, Ilya G., et al.
Publicado: (2017)

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
por: Cloux, Anne-Julie, et al.
Publicado: (2019)

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
por: Kiener, Peter A., et al.
Publicado: (1997)

FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells
por: Warlich, Eva, et al.
Publicado: (2014)

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012)

Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection
por: Krzyzowska, M, et al.
Publicado: (2011)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
por: Ikomey, George M, et al.
Publicado: (2012)

P1348: COMPARISON OF NATURAL KILLER CELL RECONSTITUTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION DEPENDING ON THE VARIANT OF T-CELL DEPLETION
por: Konova, Z., et al.
Publicado: (2022)

αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes
por: Merli, Pietro, et al.
Publicado: (2022)

Membrane-bound but not Secreted Fas Ligand Is Essential for Fas-Induced Apoptosis and Prevention of Autoimmunity and Cancer
por: O' Reilly, Lorraine A., et al.
Publicado: (2009)

Impaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice
por: Yin, Xiao-Tang, et al.
Publicado: (2015)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

Tracking the Prevalence of FAS
por: Cordero, José F., et al.
Publicado: (1994)

Triazolophostins: a library of novel and potent agonists of IP(3) receptors
por: Vibhute, Amol M., et al.
Publicado: (2015)

New transgenic mouse models enabling pan-hematopoietic or selective hematopoietic stem cell depletion in vivo
por: Rodriguez y Baena, Alessandra, et al.
Publicado: (2022)

Delineating the activity of the potent nicotinic acetylcholine receptor agonists (+)-anatoxin-a and (−)-hosieine-A
por: Parker, Holly P., et al.
Publicado: (2022)

Intervention and the Child With FAS
por: Weiner, Lyn, et al.
Publicado: (1994)

Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
por: Joashi, U, et al.
Publicado: (2001)

FAS system deregulation in T-cell lymphoblastic lymphoma
por: Villa-Morales, M, et al.
Publicado: (2014)

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
por: Mamcarz, Ewelina, et al.
Publicado: (2019)

Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection
por: Shams, Keivan, et al.
Publicado: (2019)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_s8al0bp5h8u497qu7sf1mil594